N/A N=90 Lung Cancer Exercise Training Study
Lung Cancer
Primary: Changes in VO2peak (on Exercise Capacity) — 17.9; 15.2; 15.2; 14.5 mL/kg/min
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=72 Treatment of Pruritus With Intramuscular Promethazine
Pruritus · Pregnancy Related
Primary: Does the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery? — 22; 17; 10; 15 Participants
Phase 1 N=18 Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
Acute Myeloid Leukemia
Primary: Maximum Tolerated Dose (MTD) of Venetoclax When Administered With Gemtuzumab Ozogamicin (GO) — 600 mg
N/A N=160 Physical Activity Intervention for Adolescent Girls
Physical Activity
Primary: Objectively Measured Weekly Minutes of Activity — 64; 41 weekly minutes of activity — p=0.04
N/A N=26 Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury
Amnestic Mild Cognitive Impairment · Traumatic Brain Injury · Mild Traumatic Brain Injury
Primary: Hopkins Verbal Learning Test-Revised Total Learning — 35.8; 35.9; 34.2; 31.6 T-score on a scale
N/A N=50 Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Health Behavior · Colorectal Cancer · Influenza
Primary: Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms — 17; 8 Participants
Phase 4 N=42 The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers
Dry Eye
Primary: Difference in Contact Lens-related Discomfort at 12 Weeks Compared to Baseline — 71; 11 score on a scale — p=<0.01
Phase 2 N=80 The Role of Probiotics in HIV Patients With Immunological Non-Responder
HIV Infections · Immunological Abnormality
Primary: CD4+ Level — 162.3; 50.5; 143.3; 69.9 cell/μL — p=0.02
Phase 1 N=294 Melatonin Use After Primary Total Joint Arthroplasty
Osteo Arthritis Knee
Primary: Change in Sleep Disturbance as Measured by Epworth Sleep Score (ESS) — 7.2; 6.2; 6; 6.8 score on a scale
Phase 2 N=1 Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Primary: Measurement of Serum Lactate Dehydrogenase (LDH) — 2913; 3056; 1453; 564 U/L
N/A N=100 Validation of a Vital Signs Monitoring Wristband
Coronary Artery Disease
Primary: RMSE of Heart Rate — 1.3 beats per minute
N/A N=42 FACE for Children With Rare Diseases
Rare Diseases
Primary: Beck Anxiety Inventory — 10.4; 9.5; 11.1; 8.5 score on a scale — p=0.835
Phase 4 N=20 Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
Aging · Diabetes Mellitus, Type 2 · PreDiabetes
Primary: Lean Body Mass Change — -1730.6; -421 g
N/A N=97 Text4Father Pilot Feasibility, Acceptability Study
Fathers · Mhealth · Mobile Health
Primary: Feasibility of Overall Recruitment — 53; 44 Participants
N/A N=264 Patient Priority Care for Older Adults With Multiple Chronic Conditions
Multiple Chronic Conditions
Primary: Treatment Burden — 11.9; 11.6; 12.7; 17.9 score on a scale